NCT06784466View on ClinicalTrials.gov

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

NARecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

August 31, 2027

Conditions
Atrial Fibrillation (AF)Persistant Atrial FibrillationParoxysmal AF
Interventions
DEVICE

Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System

Ablation using the Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System

Trial Locations (5)

10000

NOT_YET_RECRUITING

KBC Zagreb, Zagreb

78705

NOT_YET_RECRUITING

Texas Cardiac Arrhythmia Research Foundation, Austin

HR 21000

RECRUITING

KBC Split, Split

150 30

NOT_YET_RECRUITING

Nemocnice Na Homolce, Prague

LT-08406

RECRUITING

Vilnius University Hospital Santariskiu Klinikos, Vilnius

Sponsors

Lead Sponsor

Arga Medtech SA
All Listed Sponsors
lead

Arga Medtech SA

INDUSTRY

NCT06784466 - Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter